Cyclophosphamide Plus Transplantation of Partially HLA-mismatched, CD8+ T Cell-depleted Peripheral Blood Cells for Patients With Myelodysplastic Syndrome , Refractory Acute Myeloid Leukemia, Refractory Lymphoma or Myeloproliferative Disorders
This study has been terminated.
( Poor accrual )
Study NCT00356928
Information provided by Sidney Kimmel Comprehensive Cancer Center
First Received on July 26, 2006.
Last Updated on January 25, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
